Novartis receives US FDA approval for cell therapy to treat lymphoma
Cell therapy Kymriah is also approved for adults with high grade B-cell lymphoma and diffuse large B-cell lymphoma arising from…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 165
Browsing Category
Latest Updates
RPG Life Sciences revenue grows by 17%
EDITDA margins improves from 7.6 per cent to 10.7 per cent
Zydus Cadila to market Bumetanide tablets for edema treatment
The company has received final approval from US FDA
Ajanta Pharma posts PAT of Rs 94 crore in Q4 FY 2018
In year ended FY 2018, the company's income from operations was at Rs 2,131 crore against Rs 2,002 crore
Verseon presents new efficacy results on oral diabetic macular edema drug candidate at ARVO 2018
Verseon’s oral plasma kallikrein inhibitors successfully reduce retinal thickness and retinal leakage, two hallmarks of the…
AstraZeneca increases awareness on asthma, educates traffic personnel in Bengaluru
Distributes over 500 anti-pollution masks to traffic control officers
Strides Shasun gets US FDA nod for generic of Amgen’s Sensipar tabs
It is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease on dialysis
Cipla receives US FDA approval
The company received the approval for Generic Vazculep, Generic Phenylephrine Hydrochloride Injection USP, 10 mg/mL Single-Dose…
MoH&FW regulates manufacture, sale and import of Oxytocin in India
The regulations with regard manufacture of Oxytocin for domestic use will come into force on July 1, 2018
BI organises annual pharma conference in Ingelheim
Company posts 2017 results, 65 journalists from across the globe take part in the conference